GENNENTECH"S BUSINESS RESULTS ON JULY 11,2001

NDReg1

Date: 20 Mar 2008
Time: 19:36:13

Comments

Date: 02 Jul 2001
Time: 11:54:55

Comments

From Genentech, Inc. (DNA - NYSE) will announce its 2001 2nd quarter earnings on Wednesday, July 11, 2001, after the markets close. The announcement will be followed by a live webcast at 2:30 p.m. (PDT) of a discussion by Genentech management of the earnings and other business results. The webcast can be accessed by going to Genentech's web site at www.gene.com and will be archived and available for replay until close of business on July 18, 2001.

An audio replay of the webcast will be available beginning at 4:30 p.m. PDT on July 11, 2001 through 4:30 p.m. on July 18, 2001. Access numbers for this replay are: 1-800-633-8284 (domestic) and 1-858-587-5842 (international); passcode number is 19096046.

Genentech, Inc. is a leading biotechnology company that discovers, develops, manufactures and markets human pharmaceuticals for significant unmet medical needs. Fourteen of the currently approved biotechnology products stem from Genentech science. Genentech markets nine biotechnology products directly in the United States. The company has headquarters in South San Francisco, California and is traded on the New York Stock Exchange under the symbol DNA.

Contact:

Genentech, Inc. Sabrina Johnson, 650/225-2742 (Media) Susan Bentley, 650/225-1034 (Investor) www.gene.com

Prohost is an independent publication providing information on biotech companies. Prohost does not accept compensation from companies that are featured or profiled. It is strongly recommended that any purchase or sale decisions to any of the featured companies be discussed with a financial advisor or broker prior to completing any such purchase or sale decision. All statements or expressions are the opinion of Prohost and are not meant to be a solicitation or recommendation to buy, sell, or hold securities. Investing in embryonic companies, micro-cap and growth securities is highly speculative and carries a high degree of risk. It is possible that an investor can lose all of his/her investment in this type of companies that are profiled. The information that Prohost relies on is either through the profiled company, news services, research reports, interviews, or other outside sources that Prohost believes are reliable. Prohost makes no representations, warranties or guarantees as to the accuracy or completeness of the disclosure of the profiled companies and accepts no responsibilities for inaccuracies or misleading content in any material supplied by those clients. There can be no assurance that future events relating to the profiled company will occur as anticipated. The information contained herein is provided as an information service only. Past performance of featured companies does not guarantee the future success of any currently featured or profiled company. We encourage our readers to invest carefully and read the investor information provided by the Securities and Exchange Commission ("SEC") and/or the National Association of Securities Dealers ("NASD"). We also strongly recommend that you read the SEC advisory to investors concerning Internet Stock Fraud, which can be found at http://www.sec.gov/consumer/cyberfr.htm.

Prohost Biotechnology Online

The Newsletter of Biotechnology Research and Investment

P R O H O S T O n l i n e
The Newsletter of Biotechnology Insight and Investment

Eye on the News